InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,508.00
(
0.51%
)
Dow Jones
38,834.86
(
0.00%
)
Brent Oil
84.78
(
0.09%
)
Bitcoin
66,204.17
(
1.90%
)
Post# of 252256
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: biomaven0 post# 137085

Thursday, 02/16/2012 1:24:10 PM

Thursday, February 16, 2012 1:24:10 PM

Post# of 252256
Doebele et. al. also found diverse mechanisms (even two different ones in one lung cancer patient's tumor) of acquired resistance to crizotinib:

http://www.ncbi.nlm.nih.gov/pubmed/22235099

Also in the same issue of Science Translational Medicine where Katayama published (posted by ariadndndough in #msg-72153321), there is a good overview (I have the paper if you or anyone wants to read):

http://www.ncbi.nlm.nih.gov/pubmed/22323827
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up